CDX2 and gastric cancer: The increased rate of mutations in the WNT/APC/β-catenin pathway observed in CDX2-induced gastric cancers with SOX2 suppression may serve to reinforce CDX2 expression in these cancers, as WNT signaling is an inducer of CDX2 transcription [35].